Literature DB >> 370088

Levallorphan-tolerant mutants of Excherichia coli with altered morphologies.

G Frelat, P L Boquet.   

Abstract

The penetration of levallorphan, a synthetic morphinan known to interact with the cytoplasmic membrane of E. coli, is seriously limited by the outer membrane. To select target-resistant mutants rather than outer membrane mutants, a two-step procedure was developed, which involved the selection by penicillin of an "intermediate" parental strain with a decreased penetration barrier and a subsequent positive selection of levallorphan-tolerant pseudo-revertant clones. Unlike the direct selection, this technique yielded various types of mutants in which the morphology, the septation ability, and the growth rate were greatly affected.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 370088      PMCID: PMC218387          DOI: 10.1128/jb.137.2.1013-1016.1979

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  6 in total

1.  Inhibition of amino acid transport in Escherichia coli cells and its cell membranes.

Authors:  H Knape; P L. Boquet; R Röschenthaler
Journal:  FEBS Lett       Date:  1972-01-01       Impact factor: 4.124

Review 2.  Recalibrated linkage map of Escherichia coli K-12.

Authors:  B J Bachmann; K B Low; A L Taylor
Journal:  Bacteriol Rev       Date:  1976-03

Review 3.  Bacteriophage receptors.

Authors:  A A Lindberg
Journal:  Annu Rev Microbiol       Date:  1973       Impact factor: 15.500

4.  On the bactericidal action of levallorphan. Irreversible alterations of the plasmic membrane.

Authors:  P Boquet; M Devynck; H Aurelle; P Fromageot
Journal:  Eur J Biochem       Date:  1971-08-25

5.  Effect of levorphanol on putrescine transport in Escherichia coli.

Authors:  E J Simon; L Schapira; N Wurster
Journal:  Mol Pharmacol       Date:  1970-11       Impact factor: 4.436

6.  On the mode of action of levallorphan on Escherichia coli: effects on cellular magnesium.

Authors:  M A Devynck; P L Boquet; P Fromageot
Journal:  Mol Pharmacol       Date:  1971-11       Impact factor: 4.436

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.